Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.

Medicine - 1 Aug 2016

Li Min-Ran, Lu Jian-Hua, Ye Li-Hong, Sun Xing-Li, Zheng Yan-Hua, Liu Zhi-Quan, Zhang Hai-Cong, Liu Yun-Yan, Lv Ying, Huang Yan, Dai Er-Hei

Abstract excerpt

Previous studies have shown that hepatitis B core antibody (anti-HBc) levels vary during different phases of disease in treatment-naïve chronic hepatitis B (CHB) patients and can be used as a predictor of both interferon-α and nucleoside analogue therapy response. However, there is no information on the association between the quantitative serum anti-HBc (qAnti-HBc) level and liver inflammation in CHB patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Aspartate Aminotransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Antibodies

Share to Hepatitis B, Chronic

Share to Hepatitis B Core Antigens

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 27559949
DOI: 10.1097/MD.0000000000004422
PMCID: PMC5400315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.PMID 27559949Read ↗

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Semantic proximity Read ↗

Stronger HBc-specific B cell activity in chronic HBV-infected children with higher liver inflammatory grade and better antiviral therapy responseSemantic proximity Read ↗

Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.Semantic proximity Read ↗

Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?Semantic proximity Read ↗

Hepatitis B core-related antigen: a novel biomarker for chronic hepatitis B treatment.Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.Semantic proximity Read ↗

Innate and Adaptive Immune Responses in Chronic Hepatitis C Virus and Hepatitis B Virus Infection with High Viral LoadsSemantic proximity Read ↗

Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.Semantic proximity Read ↗

Baseline profile of intrinsic cytokines predicting prognosis of chronic hepatitis B patients responding to HBV therapeutic vaccinationsSemantic proximity Read ↗

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.Semantic proximity Read ↗

How Effective Are Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B? Serum Scoring Systems and Liver FibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.